RVTY - REVVITY, INC.
Close
112.4
-12.180 -10.836%
Share volume: 0
Last Updated: Tue 24 Dec 2024 06:01:07 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$124.58
-12.18
-9.78%
Fundamental analysis
37%
Profitability
18%
Dept financing
39%
Liquidity
75%
Performance
45%
Performance
5 Days
-0.20%
1 Month
-2.02%
3 Months
-7.99%
6 Months
7.36%
1 Year
4.30%
2 Year
-19.87%
Key data
Stock price
$112.40
DAY RANGE
$112.01 - $124.58
52 WEEK RANGE
$100.49 - $129.50
52 WEEK CHANGE
$1.49
DIVIDEND
$0.07
EX-DIVIDEND DATE
07/19/2024
NEXT EARNINGS DATE
10/30/2024
Company detail
CEO: Prahlad R. Singh
Region: US
Website: perkinelmer.com
Employees: 16,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: perkinelmer.com
Employees: 16,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Recent news